Cargando…

ETV4: an emerging target in pancreatic cancer

Detalles Bibliográficos
Autores principales:	Deshmukh, Sachin Kumar, Singh, Ajay P., Singh, Seema
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Research Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6231443/ https://www.ncbi.nlm.nih.gov/pubmed/30460327 http://dx.doi.org/10.18632/oncoscience.471

Ejemplares similares

p-21 activated kinase 4 (PAK4) maintains stem cell-like phenotypes in pancreatic cancer cells through activation of STAT3 signaling
por: Tyagi, Nikhil, et al.
Publicado: (2015)

Small Molecule KRAS Inhibitors: The Future for Targeted Pancreatic Cancer Therapy?
por: Gillson, Josef, et al.
Publicado: (2020)

Cellular and Molecular Progression of Prostate Cancer: Models for Basic and Preclinical Research
por: Saranyutanon, Sirin, et al.
Publicado: (2020)

Pancreatic cancer microenvironment, to target or not to target?
por: Carr, Ryan M, et al.
Publicado: (2016)

Structured and disordered regions cooperatively mediate DNA-binding autoinhibition of ETS factors ETV1, ETV4 and ETV5
por: Currie, Simon L., et al.
Publicado: (2017)

Extracellular Nanovesicles: From Intercellular Messengers to Efficient Drug Delivery Systems
por: Deshmukh, Sachin Kumar, et al.
Publicado: (2021)

Specific and redundant activities of ETV1 and ETV4 in prostate cancer aggressiveness revealed by co-overexpression cellular contexts
por: Mesquita, Diana, et al.
Publicado: (2015)

Etv4 and Etv5 are required downstream of GDNF and Ret for kidney branching morphogenesis
por: Lu, Benson, et al.
Publicado: (2009)

Gemcitabine treatment promotes immunosuppressive microenvironment in pancreatic tumors by supporting the infiltration, growth, and polarization of macrophages
por: Deshmukh, Sachin Kumar, et al.
Publicado: (2018)

Resistin Induces LIN28A-Mediated Let-7a Repression in Breast Cancer Cells Leading to IL-6 and STAT3 Upregulation
por: Deshmukh, Sachin Kumar, et al.
Publicado: (2021)

Therapies Targeted to Androgen Receptor Signaling Axis in Prostate Cancer: Progress, Challenges, and Hope
por: Saranyutanon, Sirin, et al.
Publicado: (2019)

RNF4 interacts with multiSUMOylated ETV4
por: Aguilar-Martinez, Elisa, et al.
Publicado: (2017)

Portrait of Molecular Signaling and Putative Therapeutic Targets in Prostate Cancer with ETV4 Fusion
por: Shin, Ye Ji, et al.
Publicado: (2022)

HER3- A key survival pathway and an emerging therapeutic target in metastatic colorectal cancer and pancreatic ductal adenocarcinoma
por: Desai, Omkar, et al.
Publicado: (2023)

Severe Acute Hepatitis: An Emerging Grave Illness in Children
por: Singh, Raghvendra, et al.
Publicado: (2023)

Autophagy in pancreatic cancer
por: Guo, Congting, et al.
Publicado: (2021)

Capicua suppresses colorectal cancer progression via repression of ETV4 expression
por: Lee, Jeon-Soo, et al.
Publicado: (2020)

Identification and characterization of novel ETV4 splice variants in prostate cancer
por: Cosi, Irene, et al.
Publicado: (2023)

Structures of the Ets Protein DNA-binding Domains of Transcription Factors Etv1, Etv4, Etv5, and Fev: DETERMINANTS OF DNA BINDING AND REDOX REGULATION BY DISULFIDE BOND FORMATION
por: Cooper, Christopher D. O., et al.
Publicado: (2015)

Exosomes: Emerging Players of Intercellular Communication in Tumor Microenvironment
por: Maheshwari, Shrankhla, et al.
Publicado: (2014)

Drug-loaded exosomal preparations from different cell types exhibit distinctive loading capability, yield, and antitumor efficacies: a comparative analysis
por: Kanchanapally, Rajashekhar, et al.
Publicado: (2019)

Targeting desmoplasia in pancreatic cancer as an essential first step to effective therapy
por: Ebelt, Nancy D., et al.
Publicado: (2020)

Primary Immune Deficiencies – A rapidly emerging area of basic and clinical research
por: Singh, Surjit, et al.
Publicado: (2020)

Exosomal Formulation Escalates Cellular Uptake of Honokiol Leading to the Enhancement of Its Antitumor Efficacy
por: Kanchanapally, Rajashekhar, et al.
Publicado: (2020)

Epigallocatechin Gallate-Gold Nanoparticles Exhibit Superior Antitumor Activity Compared to Conventional Gold Nanoparticles: Potential Synergistic Interactions
por: Chavva, Suhash Reddy, et al.
Publicado: (2019)

Heidelberg ETV score to assess success of ETV in patients with occlusive hydrocephalus: a retrospective single-center study
por: Issa, Mohammed, et al.
Publicado: (2023)

Diabetic retinopathy screening at primary and community health centers in Maharashtra
por: Shukla, Ajay K, et al.
Publicado: (2020)

p-21 activated kinase 4 promotes proliferation and survival of pancreatic cancer cells through AKT- and ERK-dependent activation of NF-κB pathway
por: Tyagi, Nikhil, et al.
Publicado: (2014)

Targeting CD44 as a novel therapeutic approach for treating pancreatic cancer recurrence
por: Molejon, Maria Inés, et al.
Publicado: (2015)

Pancreatic cancer driver mutations are targetable through distant alternative RNA splicing dependencies
por: Kawalerski, Ryan R., et al.
Publicado: (2021)

Impact of COVID-19 Pandemic on Ovarian Cancer Management: Adjusting to the New Normal
por: Jacome, Lizbeth Soto, et al.
Publicado: (2021)

Spreading Senescent Cells’ Burden and Emerging Therapeutic Targets for Frailty
por: Marcozzi, Serena, et al.
Publicado: (2023)

YK-4-279 Inhibits ERG and ETV1 Mediated Prostate Cancer Cell Invasion
por: Rahim, Said, et al.
Publicado: (2011)

Pancreatic Cancer Related Health Disparities: A Commentary
por: Scarton, Lisa, et al.
Publicado: (2018)

ETV3 and ETV6 enable monocyte differentiation into dendritic cells by repressing macrophage fate commitment
por: Villar, Javiera, et al.
Publicado: (2022)

Description of an Institutional Cohort of Myeloid Neoplasms Carrying ETV6-Locus Deletions or ETV6 Rearrangements
por: Papadopoulou, Vasiliki, et al.
Publicado: (2023)

Targeting cancer associated fibroblasts to enhance immunotherapy: emerging strategies and future perspectives
por: Hanley, Christopher J., et al.
Publicado: (2021)

ERG is specifically associated with ETS-2 and ETV-4, but not with ETS-1, in prostate cancer
por: ADLER, DAVID, et al.
Publicado: (2012)

miR-129-5p inhibits prostate cancer proliferation via targeting ETV1
por: Gao, Ge, et al.
Publicado: (2019)

Pancreatic Cancer From the Patient Perspective: The Time to Act is Now
por: Vitaloni, Marianna, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_t504u8j7s5g8kvl2chreholnuf